(Q37883018)

24 August 2017

1 reference

title

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. (English)

1 reference

24 August 2017

1 reference

1 reference

1

Deborah P M Symmons

1 reference

24 August 2017

Sherine E Gabriel

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

31 May 2011

1 reference

Nature Reviews Rheumatology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

399-408

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2011.75

24 August 2017

exact match

0 references

cites work

The bimodal mortality pattern of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

The mortality of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Patterns of cardiovascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

The widening mortality gap between rheumatoid arthritis patients and the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Cardiovascular outcomes in systemic lupus erythematosus: big studies for big questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Outcomes in patients with rheumatoid arthritis and myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Poor outcomes after acute myocardial infarction in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Insulin resistance and impaired beta cell function in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Cardiovascular outcomes in male veterans with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Autoantibodies and the risk of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Effect of rheumatoid factor on mortality and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Length of life and cause of death in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Rheumatoid arthritis and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Inverse association between obesity and antinuclear antibodies in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Cardiac involvement in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Risk factors for coronary artery disease in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Autoantibodies predicting death due to cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Vascular events in hypertensive patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.75

Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors.

31 March 2020

1 reference

12 December 2020

Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset

1 reference

12 December 2020

Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis

1 reference

12 December 2020

An update on mortality in systemic lupus erythematosus

1 reference

12 December 2020

All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database.

1 reference

12 December 2020

Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry

1 reference

12 December 2020

Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.

1 reference

12 December 2020

Mortality trends in rheumatoid arthritis: the role of rheumatoid factor

1 reference

12 December 2020

Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.

1 reference

12 December 2020

Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench

1 reference

12 December 2020

Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics

1 reference

12 December 2020

Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus

1 reference

12 December 2020

Mortality in rheumatoid arthritis: 2008 update.

1 reference

12 December 2020

Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2011.75

1 reference

24 August 2017

1 reference